Immunosuppressive therapy of immunoinflammatory diseases.
D000015:Abnormalities, Multiple / Q000139:chemically induced; D000022:Abortion, Spontaneous / Q000139:chemically induced; D003095:Collagen Diseases / Q000276:immunology; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005767:Gastrointestinal Diseases / Q000276:immunology; D006402:Hematologic Diseases / Q000276:immunology; D007154:Immune System Diseases / Q000188:drug therapy*; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000276:immunology; D007677:Kidney Function Tests; D007970:Leukopenia / Q000139:chemically induced; D008111:Liver Function Tests; D008223:Lymphoma / Q000139:chemically induced; D015122:Mercaptopurine / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D009422:Nervous System Diseases / Q000276:immunology; D011247:Pregnancy
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D015122:Mercaptopurine; D008727:Methotrexate